Learning Objectives

  1. List the major clinical phenotypes of fragile X syndrome.
  2. Describe the basic biology of SARS-CoV-2 RNA.
  3. Discuss the potential utility of re-purposing mGluR5 inhibitors to reduce virus reproduction.




Session date: 
05/11/2020 - 4:00pm to 5:00pm CDT
1220 Medical Foundation Centennial Building
1685 Highland Ave
Madison, WI 53705
United States
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.
Discloser List CME Internal Report
Cara Westmark, PhD